Skip to main content
. 2015 Aug 6;61(11):1732–1741. doi: 10.1093/cid/civ669

Table 3.

Correlates of Awareness of Human Immunodeficiency Virus-Positive Status Among Men Who Have Sex With Men and Persons Who Inject Drugs Across 27 Sites in India (n = 4052)a

Correlate MSM (n = 1146)
PWID (n = 2906)
Unadjusted
Adjusted
Unadjusted
Adjusted
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age (per 10 y) 2.66 2.17–3.26 2.11 1.63–2.74 1.50 1.26–1.77 1.26 0.99–1.61
Sex
 Male Reference Reference
 Female 2.88 1.69–4.91 4.33 2.36–7.96
Sexual identity
 Panthi (penetrative) Reference
 Kothi (receptive) 1.86 0.75–4.60
 Double-decker (both) 0.86 0.26–2.89
 Gay/MSM 1.03 0.25–4.22
 Bisexual 0.92 0.30–2.86
Marital status
 Never married Reference Reference Reference
 Currently married or living with partner 2.89 1.79–4.65 1.85 1.06–3.23 1.40 0.90–2.18
 Widowed, divorced, or long-term partner 3.72 2.03–6.80 2.73 1.80–4.14 1.34 1.02–1.76
Educational level
 Primary school or less Reference Reference Reference
 Secondary school 1.04 0.54–2.00 1.22 0.90–1.65 1.24 0.90–1.71
 High school graduate 0.57 0.24–1.34 1.50 1.03–2.21 1.59 1.07–2.35
Personal monthly income, $
 <50 Reference Reference Reference
 50–115 0.59 0.32–1.09 0.57 0.40–0.80 0.66 0.47–0.93
 >115 0.46 0.23–0.85 0.69 0.47–1.01 0.73 0.50–1.07
Homeless 0.48 0.14–1.65 0.48 0.14–1.65
Incarcerated in prior 6 mo 0.54 0.18–1.60 0.50 0.26–0.97
Ever injected drugs 0.24 0.04–1.35
Time since 1st injection (per 10 y) 1.49 1.22–1.83 1.32 1.04–1.66
Ever shared needle or syringe 0.28 0.08–0.94 1.47 1.06–2.03 1.56 1.06–2.30
Injection frequency in prior 6 mo
 None Reference Reference Reference
 Less than daily 0.85 0.16–4.40 0.62 0.38–1.02 0.72 0.43–1.21
 Daily 0.07 0.01–0.59 0.40 0.27–0.61 0.46 0.27–0.79
Alcohol use (AUDIT)
 None or limited use Reference Reference Reference
 Harmful or hazardous use 0.30 0.14–0.68 0.22 0.11–0.42 0.73 0.49–1.09
 Alcohol dependence 0.14 0.06–0.35 0.09 0.03–0.30 0.60 0.30–1.19
No. of lifetime sexual partners (per 10 partners) 1.01 1.01–1.02 0.99 0.97–1.02
Lifetime male sexual partners, No.
 1–5 Reference Reference
 6–15 0.50 0.26–0.96 0.57 0.31–1.08
 16–60 0.64 0.35–1.17 0.50 0.25–0.99
 61–300 1.33 0.75–2.34 1.44 0.81–2.55
 ≥300 2.01 1.05–3.87 2.42 1.13–5.16
Disclosed MSM to anyone 1.50 0.94–2.38
Lifetime history of sex work 1.75 1.23–2.49 0.85 0.33–2.17
Lifetime history of STI 3.41 2.07–5.62 3.49 1.93–6.32
Any history of tuberculosis diagnosis 16.11 5.33–48.7 26.5 7.21–97.1 2.88 1.74–4.76 2.53 1.52–4.20
Ever visited NEP 0.24 0.04–1.36 1.08 0.69–1.69
Ever visited OAT 0.11 0.02–0.80 2.03 1.44–2.85 2.28 1.59–3.27
Region (PWID)
 North/central India Reference
 Northeastern India 5.62 1.69–18.7 2.99 0.97–9.17
Region (MSM)
 Central/north Reference Reference
 Karnataka 3.09 0.41–23.1 4.40 0.40–48.70
 Tamil Nadu 26.0 2.97–228.7 31.9 2.34–433.6
 Andhra Pradesh 6.76 1.01–45.0 8.77 0.91–84.6
No. of ICTCs in city (per 5 centers)b 1.20 1.06–1.37 1.22 1.06–1.40 0.80 0.47–1.36
No. of ART centers in city (per 1 center)b 1.43 1.00–2.04 1.47 1.04–2.09 1.02 0.91–1.40
No. of MSM-focused TIs in state (per 1 TI) 0.98 0.90–1.06
% of TIs that were MSM focused (per 10%) 0.93 0.30–2.85
No. of PWID-focused TIs in state (per 1 TI) 1.00 0.97–1.04
% of TIs that were PWID-focused (per 10%) 1.31 0.98–1.74

Abbreviations: ART, antiretroviral therapy; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; ICTCs, integrated counseling and testing centers; MSM, men who have sex with men; NEP, needle exchange program; OAT, opioid agonist therapy; OR, odds ratio; PWID, persons who inject drugs; STI, sexually transmitted infection; TIs, targeted intervention.

a Models incorporated scaled respondent-driven sampling (RDS) II weights; see Supplementary materials for unweighted model results.

b Separate multivariable models were constructed using these variables, given collinearity with the region variable.